Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis

References

• Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367–1380.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
   PubMed Web of Science ®Google Scholar
• He Y, Wang L, Liu W, et al. MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer. Sci Rep. 2015;5(1):11471.
   PubMedGoogle Scholar
• Motoi N, Szoke J, Riely GJ, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol. 2008;32(6):810–827.
   PubMedGoogle Scholar
• Nadal E, Truini A, Nakata A, et al. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 2015;5(1):12464.
   PubMedGoogle Scholar
• Dhanasekaran SM, Balbin OA, Chen G, et al. Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes. Nat Commun. 2014;5(1):5893.
   PubMed Web of Science ®Google Scholar
• Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455(7216):1069–1075.
   PubMed Web of Science ®Google Scholar
• Balbin OA, Malik R, Dhanasekaran SM, et al. The landscape of antisense gene expression in human cancers. Genome Res. 2015;25(7):1068–1079.
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223–227.
   PubMed Web of Science ®Google Scholar
• Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–669.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Iyer MK, Balbin OA, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29(8):742–749.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–1307.
   PubMed Web of Science ®Google Scholar
• Carpenter S, Aiello D, Atianand MK, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science. 2013;341(6147):789–792.
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu N, Wang JP, et al. Regulatory long non-coding RNA and its functions. J Physiol Biochem. 2012;68(4):611–618.
   PubMed Web of Science ®Google Scholar
• Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013;12(6):433–446.
   PubMed Web of Science ®Google Scholar
• Yang F, Huo XS, Yuan SX, et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013;49(6):1083–1096.
   PubMed Web of Science ®Google Scholar
• Yang L, Lin C, Jin C, et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 2013;500(7464):598–602.
   PubMed Web of Science ®Google Scholar
• Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477(7364):295–300.
   PubMed Web of Science ®Google Scholar
• Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409–419.
   PubMed Web of Science ®Google Scholar
• Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9(3):e1003368.
   PubMed Web of Science ®Google Scholar
• Corrigendum. Cancer control: journal of the Moffitt Cancer Center. Cancer Control: Journal of the Moffitt Cancer Center. 2018;25(1):1073274818821765.
   Google Scholar
• Zhang YX, Yuan J, Gao ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway. Eur Rev Med Pharmacol Sci. 2018;22(2):443–449.
   PubMed Web of Science ®Google Scholar
• Shen D, Li J, Tao K, et al. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. Bioengineered. 2021;12(1):3525–3538.
   PubMed Web of Science ®Google Scholar
• Rios-Romero M, Cedro-Tanda A, Pena-Luna M, et al. FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients. Sci Rep. 2020;10(1):14145.
   PubMed Web of Science ®Google Scholar
• Zhang J, Feng S, Su W, et al. Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Sci Rep. 2017;7(1):42819.
   PubMedGoogle Scholar
• Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1(1):15004.
   PubMedGoogle Scholar
• Chen S, Lu S, Yao Y, et al. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging. Aging (Albany NY). 2020;12(14):14329–14340.
   PubMedGoogle Scholar
• Li H, Liu F, Qin W. Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis. Cancer Cell Int. 2020;20(1):78.
   PubMed Web of Science ®Google Scholar
• Nagai N, Habuchi H, Esko JD, et al. Stem domains of heparan sulfate 6-O -sulfotransferase are required for Golgi localization, oligomer formation and enzyme activity. J Cell Sci. 2004;117(15):3331–3341.
   PubMed Web of Science ®Google Scholar
• Sasisekharan R, Shriver Z, Venkataraman G, et al. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer. 2002;2(7):521–528.
   PubMed Web of Science ®Google Scholar
• Di Maro G, Orlandella FM, Bencivenga TC, et al. Identification of targets of Twist1 transcription factor in thyroid cancer cells. J Clin Endocrinol Metab. 2014;99(9):E1617–26.
   PubMed Web of Science ®Google Scholar
• Schulten HJ, Al-Mansouri Z, Baghallab I, et al. Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid. BMC Genomics. 2015;16(Suppl S1):S7.
   PubMedGoogle Scholar
• Hatabe S, Kimura H, Arao T, et al. Overexpression of heparan sulfate 6-O-sulfotransferase-2 in colorectal cancer. Mol Clin Oncol. 2013;1(5):845–850.
   PubMedGoogle Scholar
• Ahmed F. Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer. Front Oncol. 2019;9:1011.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego. Calif). 2001;25(4):402–408.
   Google Scholar
• Kang J, Huang X, Dong W, et al. MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3). Bioengineered. 2021;12(1):1150–1160.
   PubMed Web of Science ®Google Scholar
• Wang X, Li T. Ropivacaine inhibits the proliferation and migration of colorectal cancer cells through ITGB1. Bioengineered. 2021;12(1):44–53.
   PubMed Web of Science ®Google Scholar
• Li X, Liu F, Lin B, et al. miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma. Int J Oncol. 2017;50(4):1097–1108.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102.
   PubMed Web of Science ®Google Scholar
• Wu Q, Lu S, Zhang L, et al. LncRNA HOXA-AS2 activates the notch pathway to promote cervical cancer cell proliferation and migration. Reprod Sci. 2021;28(10):3000–3009.
   PubMed Web of Science ®Google Scholar
• Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res off J Am Assoc Cancer Res. 2011;17(9):3029–3038.
   PubMed Web of Science ®Google Scholar
• Li YQ, Lu JH, Bao XM, et al. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. J Exp Clin Cancer Res. 2015;34(1):130.
   PubMedGoogle Scholar
• Wang S, Han C, Liu T, et al. FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma. Clin Transl Med. 2021;11(2):e316.
   PubMed Web of Science ®Google Scholar
• Liang Y, Xia W, Zhang T, et al. Upregulated Collagen COL10A1 remodels the extracellular matrix and promotes malignant progression in lung adenocarcinoma. Front Oncol. 2020;10:573534.
   PubMed Web of Science ®Google Scholar
• Guo Q, Zheng M, Xu Y, et al. MiR-384 induces apoptosis and autophagy of non-small cell lung cancer cells through the negative regulation of Collagen α-1(X) chain gene. Biosci Rep. 2019;39(2). DOI:10.1042/BSR20181523
   Google Scholar
• Motea EA, Huang X, Singh N, et al. NQO1-dependent, tumor-selective radiosensitization of non-small cell lung cancers. Clin Cancer Res off J Am Assoc Cancer Res. 2019;25(8):2601–2609.
   PubMed Web of Science ®Google Scholar
• Lou Y, Guo Z, Zhu Y, et al. Houttuynia cordata Thunb. and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumorigenesis by activating the Nrf2-HO-1/NQO-1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):242.
   PubMedGoogle Scholar
• Wang L, Chen Z, An L, et al. Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2016;38(6):2389–2400.
   PubMedGoogle Scholar
• Zhan Y, Zang H, Feng J, et al. Long non-coding RNAs associated with non-small cell lung cancer. Oncotarget. 2017;8(40):69174–69184.
   PubMedGoogle Scholar
• Yang Q, Wang J, Zhong P, et al. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis. Cancer Cell Int. 2020;20(1):72.
   PubMed Web of Science ®Google Scholar
• Wu KL, Tsai YM, and Lien CT, et al. The Roles of MicroRNA in Lung Cancer. Int J Mol Sci. 2019;20(7):1611.
   PubMed Web of Science ®Google Scholar
• Song B, Ji W, Guo S, et al. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I. FEBS Lett. 2014;588(23):4375–4381.
   PubMed Web of Science ®Google Scholar
• Ning B, Guo S, Mei Y. Long non-coding RNA CASC9 promotes tumor progression in oral squamous cell carcinoma by regulating microRNA-545-3p/laminin subunit gamma 2. Bioengineered. 2021;12(1):7907–7919.
   PubMedGoogle Scholar
• Cosin-Tomas M, Antonell A, Llado A, et al. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: potential and Limitations. Mol Neurobiol. 2017;54(7):5550–5562.
   PubMed Web of Science ®Google Scholar
• Du B, Wang Z, Zhang X, et al. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells. PLoS One. 2014;9(2):e88022.
   PubMed Web of Science ®Google Scholar
• Cui J, Pan G, He Q, et al. MicroRNA-545 targets ZEB2 to inhibit the development of non-small cell lung cancer by inactivating Wnt/beta-catenin pathway. Oncol Lett. 2019;18(3):2931–2938.
   PubMed Web of Science ®Google Scholar
• Backen AC, Cole CL, Lau SC, et al. Heparan sulphate synthetic and editing enzymes in ovarian cancer. Br J Cancer. 2007;96(10):1544–1548.
   PubMed Web of Science ®Google Scholar
• Matsuda K, Maruyama H, Guo F, et al. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res. 2001;61(14):5562–5569.
   PubMed Web of Science ®Google Scholar
• Pollari S, Kakonen RS, Mohammad KS, et al. Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis. Mol Cancer Res. 2012;10(5):597–604.
   PubMed Web of Science ®Google Scholar
• Sanderson RD. Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol. 2001;12(2):89–98.
   PubMed Web of Science ®Google Scholar
• Song K, Li Q, Peng YB, et al. Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling. Biochem J. 2011;436(2):271–282.
   PubMedGoogle Scholar